Search details
1.
Defining Intermediate Risk Prostate Cancer Suitable for Active Surveillance.
J Urol
; 201(2): 292-299, 2019 02.
Article
in English
| MEDLINE | ID: mdl-30240688
2.
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor.
Nat Chem Biol
; 13(7): 771-778, 2017 Jul.
Article
in English
| MEDLINE | ID: mdl-28530711
3.
Prognostic scoring systems for myelodysplastic syndromes (MDS) in a population-based setting: a report from the Swedish MDS register.
Br J Haematol
; 181(5): 614-627, 2018 06.
Article
in English
| MEDLINE | ID: mdl-29707769
4.
Nationwide, population-based study of post radical prostatectomy urinary incontinence correction surgery.
J Surg Oncol
; 117(2): 321-327, 2018 Feb.
Article
in English
| MEDLINE | ID: mdl-28876467
5.
Temporal trends in incidence and outcome of hydatidiform mole: a retrospective cohort study.
Acta Oncol
; 57(8): 1094-1099, 2018 Aug.
Article
in English
| MEDLINE | ID: mdl-29451409
6.
Socioeconomic factors and penile cancer risk and mortality; a population-based study.
BJU Int
; 119(2): 254-260, 2017 Feb.
Article
in English
| MEDLINE | ID: mdl-27373878
7.
Long-term adverse effects after retropubic and robot-assisted radical prostatectomy. Nationwide, population-based study.
J Surg Oncol
; 116(4): 500-506, 2017 Sep.
Article
in English
| MEDLINE | ID: mdl-28591934
8.
Risk of malignant melanoma in men with prostate cancer: Nationwide, population-based cohort study.
Int J Cancer
; 138(9): 2154-60, 2016 May 01.
Article
in English
| MEDLINE | ID: mdl-26662367
9.
Postoperative mortality 90 days after robot-assisted laparoscopic prostatectomy and retropubic radical prostatectomy: a nationwide population-based study.
BJU Int
; 118(2): 302-6, 2016 08.
Article
in English
| MEDLINE | ID: mdl-26762928
10.
Causes of death in men with localized prostate cancer: a nationwide, population-based study.
BJU Int
; 117(3): 507-14, 2016 Mar.
Article
in English
| MEDLINE | ID: mdl-25604807
11.
Prognostic implications of 2005 Gleason grade modification. Population-based study of biochemical recurrence following radical prostatectomy.
J Surg Oncol
; 114(6): 664-670, 2016 Nov.
Article
in English
| MEDLINE | ID: mdl-27511833
12.
Upper limit of cancer extent on biopsy defining very low-risk prostate cancer.
BJU Int
; 116(2): 213-9, 2015 Aug.
Article
in English
| MEDLINE | ID: mdl-25053197
13.
Use of Phosphodiesterase Type 5 Inhibitors for Erectile Dysfunction and Risk of Malignant Melanoma.
JAMA
; 313(24): 2449-55, 2015.
Article
in English
| MEDLINE | ID: mdl-26103029
14.
Population based study of predictors of adverse pathology among candidates for active surveillance with Gleason 6 prostate cancer.
J Urol
; 191(2): 350-7, 2014 Feb.
Article
in English
| MEDLINE | ID: mdl-24071481
15.
Drug prescription for erectile dysfunction before and after diagnosis of localized prostate cancer.
J Sex Med
; 11(8): 2100-8, 2014 Aug.
Article
in English
| MEDLINE | ID: mdl-24862360
16.
Work-up and treatment of prostate cancer before and after publication of the first national guidelines on prostate cancer care in Sweden.
Scand J Urol
; 52(4): 277-284, 2018 Aug.
Article
in English
| MEDLINE | ID: mdl-30362868
17.
Nationwide population-based study on the use of novel antiandrogens in men with prostate cancer in Sweden.
Scand J Urol
; 52(2): 143-150, 2018 Apr.
Article
in English
| MEDLINE | ID: mdl-29385878
18.
Uptake of Active Surveillance for Very-Low-Risk Prostate Cancer in Sweden.
JAMA Oncol
; 3(10): 1393-1398, 2017 Oct 01.
Article
in English
| MEDLINE | ID: mdl-27768168
19.
Meta-Analysis of the Association Between Phosphodiesterase Inhibitors (PDE5Is) and Risk of Melanoma.
J Natl Cancer Inst
; 109(8)2017 08 01.
Article
in English
| MEDLINE | ID: mdl-29117385
20.
Testosterone Replacement Therapy and Risk of Favorable and Aggressive Prostate Cancer.
J Clin Oncol
; 35(13): 1430-1436, 2017 May 01.
Article
in English
| MEDLINE | ID: mdl-28447913